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Introduction
The ability of cells to respond to alterations in their osmotic environment is of fundamental importance to their survival. In response to hypoosmotic stress, cells initially swell with a magnitude proportional to the reduction in osmolarity, but this is followed by a recovery process of regulatory volume decrease in which osmolytes (K + , Cl -and "compatible" organic osmolytes) are extruded and cell volume normalized following the exit of obligated water (McManus et al., 1995; Pasantes-Morales et al., 2000 . Polyols, methylamines and amino acids are the principal organic osmolytes utilized by eukaryotic cells. Of these, the amino acid taurine appears to be ideally suited because of its metabolic inertness and abundance (Lambert, 2004) . The extrusion of Cl -and organic osmolytes such as taurine is thought to occur via a volumesensitive organic osmolyte and anion channel (VSOAC) which is primarily permeable to Cl -but is impermeable to cations Lang et al.,1998; Kimelberg, 2000; Nilius and Droogmans, 2003) . The efflux of Cl -generates an outwardly rectifying current known as I Cl,swell . Regulatory volume decrease, organic osmolyte efflux and I Cl,swell can be blocked not only by non-selective Cl -channel inhibitors such as DDF or NPPB but also by the highly selective inhibitor of VSOAC, DCPIB (Decher et al., 2001; Abdullaev et al., 2006) . In addition to cell volume regulation, several other cell functions have been attributed to VSOACs. These include modulation of electrical activity, cell cycle progression, cell proliferation, apoptosis and metabolic regulation (for reviews, see Nilius et al., 1997; Lang et al., 1998; Stutzin and Hoffman, 2006) .
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When measured in vitro, the efflux of organic osmolytes is relatively insensitive to hypoosmotic stress, often requiring substantial (non-physiological) reductions in osmolarity before a significant efflux of osmolytes occurs. This observation, along with previous reports that swelling-induced osmolyte release can be enhanced by Ca 2+ ionophores, phorbol esters or agents known to elevate cAMP (Strange et al., 1993; Novak et al., 2000; Moran et al., 2001) , raises the possibility that, in vivo, the activity of VSOAC may be regulated by the activity of G-protein coupled receptors (GPCRs). In this context, we and others have recently identified a number of Ca 2+ -mobilizing GPCRs that, when activated, enhance the volume-sensitive efflux of osmolytes from both neural and non-neural cells: P2Y purinergic receptors in rat primary astrocytes Kimelberg, 2002, 2005) , H 1 histamine receptors in HeLa cells (Falktoft and Lambert, 2004) , m 3 muscarinic cholinergic (mAChR), lysophosphatidic acid and sphingosine 1-phosphate receptors in human SH-SY5Y neuroblastoma (Loveday et al., 2003; Heacock et al., 2004 Heacock et al., , 2006 and the protease-activated receptor-1 (PAR-1) in myoblasts and human 1321N1 astrocytoma (Manopoulos et al., 1997; Cheema et al., 2005) .
Receptor activation has been demonstrated to facilitate the ability of the cells to release osmolytes under conditions of very limited reductions in osmolarity (5-10%) via a mechanism that appears to involve intracellular Ca 2+ and protein kinase C (PKC) activity.
A major signal transduction pathway utilized by a large number of GPCRs is the activation of adenylyl cyclase with the concomitant formation of cAMP. In this context, the addition of forskolin, a direct activator of adenylyl cyclase, has been reported to increase osmolyte release in some, but not all, tissues (Strange et al., 1993;  This article has not been copyedited and formatted. The final version may differ from this version. (Carpenter and Peers, 1997; Du and Sorota, 1997; Nagasaki et al., 2000; Shimizu et al., 2000) . Although these results indicate a potential role for cAMP in osmoregulation, the ability of endogenously expressed adenylyl cyclase-linked receptors to regulate osmolyte efflux has not been systematically examined. In the present study, we have evaluated the ability of prostanoid receptors present in murine L fibroblasts to regulate osmolyte efflux under conditions of hypoosmotic stress. These cells are known to possess prostanoid receptors that robustly couple to adenylyl cyclase and PKA activation (Maganiello and Vaughn, 1972; Uhler and Abou-Chebl, 1992 
Measurement of taurine efflux.
Osmolyte efflux from L cells and RAB-10 cells was monitored essentially as previously described for SH-SY5Y neuroblastoma (Heacock et al., 2004 (Heacock et al., , 2006 Uptake of radiolabel into L cells was time-dependent (t 1/2 ~3h), temperature-sensitive (inhibited >98% by lowering the temperature to 4 o C) and was inhibited >70% by inclusion of a 500 µM guanidinethyl sulfonate, an inhibitor of the taurine uptake transporter (Lambert, 2004) . After prelabeling, the cells were washed with 2 x 2 ml of isotonic Buffer A (142 mM NaCl, 5.6 mM KCl, 2.2 mM CaCl 2 , 3.6 mM NaHCO 3 , 1mM
MgCl 2 and 30 mM HEPES, pH 7.4, 1 mg/ml D-glucose; approx. 335 mOsM). Cells were then allowed to incubate in 2 ml of hypotonic buffer A (295-195 mOsM; rendered hypotonic by a reduction in NaCl concentration) in the absence or presence of PGE 1 . In some experiments, buffer A was made hypertonic (370 mOsM) by the addition of NaCl.
Osmolarities of buffer A were monitored by means of an Osmette precision osmometer (PS Precision Systems, Sudbury, MA). At times indicated, aliquots (200 µl) of the extracellular medium were removed and radioactivity determined after the addition of 5
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on September 6, 2017 jpet.aspetjournals.org Downloaded from ml of Universol scintillation fluid. The reactions were terminated by rapid aspiration of the buffer and cells lysed by the addition of 2 ml of ice-cold 6% (wt/vol) trichloroacetic acid. Taurine efflux was calculated as a fractional release, i.e., the radioactivity released in the extracellular media as a percentage of the total radioactivity present initially in the cells. The latter was calculated as the sum of radioactivity recovered in the extracellular medium and that remaining in the lysate at the end of the assay (Novak et al., 1999) . "Basal" release of taurine is defined as that which occurs at a specified osmolarity in the absence of agonists or cyclic AMP analogs.
Measurement of PKA activity.
PKA activity was determined essentially as described by Uhler and McKnight (1987) . ethanol, individual filters were allowed to dry at room temperature and radioactivity determined after the addition of 5 ml of Universol scintillation fluid.
Measurement of Cytoplasmic Calcium Concentrations.
Cytoplasmic free calcium concentrations, [Ca 2+ ] i , were determined in suspensions of L cells after preloading cells with the Ca 2+ indicator, fura-2 AM, as previously described (Fisher et al., 1989) . The fluorometer used was a Shimadzu RF-5301PC spectrofluorometer (Shimadzu Scientific Instruments, Columbia, MD).
Data analysis.
Experiments were performed in triplicate and repeated at least three times. Except where stated otherwise, values quoted are given as means ± S.E.M. for the number (n) of independent experiments indicated. A two-tailed Student's t-test (paired or unpaired) was used to evaluate differences between two experimental groups (level of significance, p<0.05). One-way or repeated measures Analysis of Variance (ANOVA)
followed by Dunnett's multiple comparisons test was used for statistical significance of differences between multiple groups. EC 50 values were obtained using Prism 4.0a
(GraphPad Software, Inc. San Diego, CA).
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Osmosensitive efflux of taurine from L cells is enhanced by the addition of PGE 1 .
When L cells that had been prelabeled with [
3 H]taurine were exposed to hypotonic buffer (250 mOsM), there was a time-dependent efflux of the radiolabeled amino acid, the initial rate of which (<5 min) exceeded that observed in more prolonged incubations ( Fig. 1 ). Inclusion of PGE 1 (20 µM) significantly enhanced the rate of release of taurine at all time points examined and increased the magnitude of response to approximately 250-300 % of basal (basal release being that monitored in the absence of an agonist).
As a result of these observations, both basal and agonist-stimulated taurine efflux were routinely monitored after 10 min of incubation in subsequent experiments. During the course of the present study, some inter-experimental variability in the magnitude of the basal release of taurine (5.2 ± 2.6% of total, mean ± SD, n=65) and in the extent of PGE 1 -stimulated taurine efflux (274 ± 74% of control, mean ± SD, n=65) was observed.
The addition of PGE 1 resulted in a concentration-dependent stimulation of taurine efflux with an EC 50 value of 2.5 ± 0.4 nM (n=3) and a Hill coefficient close to unity (1.1 ± 0.2, n=3, Fig. 2 ). To determine the subtype of prostanoid receptor coupled to osmolyte efflux, L cells were incubated in the presence of 1 µM concentrations of PGE 1 , butaprost (EP 2 -selective), 17-phenyl-trinor PGE 2 (EP 1 -and EP 3 -selective) or sulprostone (EP 3 -selective). Of these analogs, only butaprost elicited a significant increase in taurine release (Fig. 3) . Moreover, as the osmolarity of the buffer was reduced, the ability of PGE 1 to enhance taurine efflux over the basal component was further increased. The maximum enhancement of taurine efflux was observed at an osmolarity of 250 mOsM (350% of basal), but not under either isotonic or mildly hypertonic conditions (Fig. 4) . As a result of these findings, an osmolarity of 250 mOsM was chosen for all subsequent experiments.
PGE 1 -mediated efflux of taurine from L cells is mediated via a VSOAC. Previously,
we demonstrated that osmolyte release triggered by the activation of mAChRs, PARs or lysophospholipid receptors is mediated via a VSOAC (Heacock et al., 2004 (Heacock et al., ,2006 Cheema et al., 2005) . To determine whether taurine release elicited by the activation of prostaglandin receptors also occurred via the same channel(s), basal and PGE 1 -stimulated taurine efflux were monitored in the presence of three putative blockers of VSOAC, namely NPPB, DDF and DCPIB. Each of these agents (at concentrations of 100 µM for DDF and NPPB or 30 µM for DCPIB) resulted in a significant inhibition of with thapsigargin (Fig. 8B) . conditions, PGE 1 -stimulated taurine efflux was not significantly reduced (177 ± 6 and 183 ± 8% of control, in the presence and absence of thapsigargin, respectively). Basal release of taurine was also unaffected by depletion of intracellular Ca 2+ . In contrast, thrombin-stimulated taurine efflux was diminished by 65% following depletion of intracellular Ca 2+ (167 ± 9% and 289 ± 47% of control, in the presence and absence of thapsigargin, respectively, p< 0.01, Fig. 9B ).
To examine the involvement of PKC in PGE 1 -and thrombin-stimulated taurine efflux, L cells were preincubated in isotonic buffer A for 15 min with 10 µM chelerythrine prior to agonist challenge under hypotonic conditions. Chelerythrine had no inhibitory effect on basal, PGE 1 -or thrombin-stimulated taurine efflux and preincubation of L cells with the PKC inhibitor slightly enhanced all three parameters (Fig. 10) . When calculated relative to their respective controls, the addition of PGE 1 increased taurine efflux to 306 ± 36 and 320 ± 44% of control in the absence or presence of chelerythrine, respectively, whereas the corresponding values for thrombin-stimulated taurine efflux were 428 ± 125 and 430 ± 136% of control, respectively, n=5, Fig.10 . In addition, chelerythrine had no effect on mAChR-stimulated taurine release from L cells that had been stably transfected with the m 3 mAChR (data not shown). The ability of Gö 6983, a highly potent cell-permeant PKC inhibitor, to inhibit PGE 1 -stimulated taurine efflux was also examined. When cells were pretreated for 15 min with 1 µM Gö 6983 and then challenged with PGE 1 , agonist-stimulated release of taurine was not significantly reduced (278 ± 12 and 284 ± 27% of basal in the absence and presence of Gö 6983, respectively, n=6). Preincubation of L cells with 1 µM bisindolylmaleimide, another broad spectrum PKC inhibitor, also had no inhibitory effect on basal, PGE 1 -or thrombinstimulated taurine efflux (data not shown).
This article has not been copyedited and formatted. The final version may differ from this version. receptor-stimulated osmolyte release also appears to require PKC activity Kimelberg, 2002, 2005; Falktoft and Lambert, 2004; Heacock et al., 2004 Heacock et al., , 2006 Cheema et al., 2005) . In the present study, we demonstrate that a GPCR that couples to adenylyl cyclase activation is also able to facilitate osmolyte release via a mechanism that is distinct from that previously described. Evidence to support the conclusion that prostanoid receptors present on mouse fibroblasts regulate osmolyte efflux via a cAMPdependent mechanism is based upon three series of experimental observations. First, the ability of PGE 1 to enhance taurine efflux could be mimicked by the addition of agents that elevate intracellular cAMP concentrations via either the inhibition of cAMP breakdown or direct activation of adenylyl cyclase or, alternatively, by acting directly as cell-permeant analogs of cAMP (Fig. 6) . Moreover, when these agents were included in incubations that contained PGE 1 , no further increase in osmolyte release was observed, a result consistent with a common mechanism of action. Second, of the PGE analogs tested, only butaprost, an analog that selectively activates the prostanoid EP 2 receptor subtype that couples to activation of adenylyl cyclase, could facilitate osmolyte release.
This article has not been copyedited and formatted. The final version may differ from this version. Third, the ability of either PGE 1 or 8-CPT-cAMP (but not that of either thrombin or sphingosine 1-phosphate) to stimulate taurine efflux was significantly attenuated in RAB-10 cells, which exhibit a lower activity of PKA than L cells. Since PKA is the major downstream cellular target for cAMP action, this result is a further indication that the cyclic nucleotide is the mediator of osmosensitive increases in taurine efflux. The conclusion that prostanoid receptor-mediated changes in cAMP can regulate taurine release is consistent with a previous study in which isoproterenol, a β-adrenergic agonist, was observed to increase osmolyte efflux from glial cells (Moran et al., 2001 ).
Taken collectively, the results indicate that receptor-mediated increases in cAMP are potentially linked to the process of osmoregulation in cells.
One complication in the interpretation of our results is that, in addition to its previously documented ability to increase the concentration of intracellular cAMP in L cells (Maganiello and Vaughn, 1972; Uhler and Abou-Chebl, 1992 20 the response, a result consistent with our previous findings in astrocytoma cells (Cheema et al., 2005) . The most parsimonious interpretation of these results is that L cells possess two populations of prostanoid receptors, one that couples to the activation of adenylyl cyclase, PKA activation and osmolyte release whereas a second group of receptors is linked to an increase in Ca 2+ mobilization. It appears that the latter population of receptors does not make a significant contribution to osmolyte release in L cells. In this context, it should be noted that distinct differences in the susceptibility of GPCR-stimulated osmolyte release to depletion of intracellular Ca2+ have been observed. Thus whereas taurine release elicited by the addition of either lysophosphatidic acid or sphingosine 1-phosphate is reduced by 30-40%, the responses to ATP and muscarinic agonists are essentially abolished (Mongin and Kimelberg, 2005; Heacock et al., 2006) . PGE 1 stimulation of taurine release also appears to be independent of PKC, as determined from the inability of chelerythrine, Gö 6983 or bisindolylmaleimide to significantly inhibit either basal-or PGE 1 -induced osmolyte release. The observation that inhibition of PKC also did not attenuate either thrombin-or mAChR-stimulated taurine release from L cells was unexpected and at variance with previous studies in which PKC activity was found to be necessary for the maximum release of osmolytes in response to either of these receptors (Cheema et al., 2005; Heacock et al., 2006) . One interpretation of the present findings is that PKC activity may not invariably be a prerequisite for agonist-stimulated osmolyte release, even for Ca 2+ -mobilizing receptors.
Although taurine release elicited by prostanoid receptor stimulation appears to differ from that exhibited by previously studied receptors in terms of its apparent lack of 21 Ca 2+ and PKC dependence, two features common to all receptors can be identified.
The first is that, similar to osmolyte release induced by Ca 2+ -mobilizing agonists, a VSOAC appears to mediate osmolyte efflux as indicated by the ability of non-selective anion channel inhibitors, such as DDF and NPPB, to block PGE 1 -stimulated taurine efflux. This conclusion is strengthened by the observation that DCPIB, a highly selective inhibitor of VSOAC (Decher et al., 2001 ) also significantly inhibits PGE 1 -stimulated taurine efflux (Fig.5) . A second characteristic shared by both the prostanoid receptor and those receptors primarily linked to Ca 2+ mobilization is a reduction in the osmotic threshold for osmolyte release following receptor activation. Thus, in the absence of PGE 1 addition, the ability of L cells to significantly respond to hypoosmotic stress is restricted to a relatively large reduction in osmolarity (>33%) whereas in the presence of the agonist, osmolyte release occurs when the osmolarity is reduced by <15% (Fig. 4) . The present results are consistent with data previously obtained for osmolyte release following agonist activation of other GPCRs such as the P2Y purinergic, m3 mAChR, PAR-1, sphingosine 1-phosphate and lysophosphatidic acid receptors Kimelberg, 2002, 2005; Heacock et al., 2004 Heacock et al., , 2006 Cheema et al., 2005) and also that elicited following activation of the epidermal growth factor receptor (Franco et al., 2004) . These results indicate that, regardless of the underlying mechanism(s) of activation, receptors coupled to osmolyte efflux share a common property in their ability to facilitate osmolyte release from cells in response to relatively small changes in osmolarity, such as those that are likely to be encountered in vivo.
In summary, the results in the present study provide evidence that prostanoid receptors coupled to an increase in cAMP concentration can facilitate osmolyte release for PGE 1 or 6 independent experiments for thrombin, each performed in triplicate,* different from Ca 2+ -containing control incubations, p<0.05 (by one-way ANOVA followed by Dunnett's multiple comparison test); **, different from Ca 2+ -free incubations, p<0.01
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